Prostate Cancer - Results from #21060

National trends in prostate cancer screening among older American men with limited 9-year life expectancies: Evidence of an increased need for shared decision making - Abstract March 13, 2014

Identification of underserved areas for urologic cancer care - Abstract March 13, 2014

Localized prostate cancer in Norway, the United States, and Spain: Between-country differences of variables before treatment among patients eligible for curative treatment - Abstract March 13, 2014

Prostate cancer that is within 0.1 mm of the surgical margin of a radical prostatectomy predicts greater likelihood of recurrence - Abstract March 13, 2014

Dosimetric considerations to determine the optimal technique for localized prostate cancer among external photon, proton, or carbon-ion therapy and high-dose-rate or low-dose-rate brachytherapy - Abstract March 13, 2014

Nadir prostate-specific antigen (PSA) level and time to PSA nadir following primary androgen deprivation therapy as independent prognostic factors in a Japanese large-scale prospective cohort study (J-CaP) - Abstract March 13, 2014

Serum biomarkers of bone metabolism in castration-resistant prostate cancer patients with skeletal metastases: Results from SWOG 0421 - Abstract March 13, 2014

Dendreon announces plans to make PROVENGE® commercially available in Europe March 13, 2014

Zoledronic acid treatment for cancerous bone metastases: A phase IV study in Taiwan - Abstract March 12, 2014

Multi-parametric magnetic resonance imaging guiding diagnostic biopsy detects significant prostate cancer, and could reduce unnecessary biopsies and over-detection: A prospective study - Abstract March 12, 2014

Statin drug use is not associated with prostate cancer risk in men who are regularly screened - Abstract March 12, 2014

A tertiary Gleason pattern in the prostatectomy specimen and its association to adverse outcome after radical prostatectomy; results of a large contemporary prostatectomy series - Abstract March 12, 2014

The roles of multiparametric MRI, PCA3, and PHI: Which is the best predictor of prostate cancer after a negative biopsy? Results of a prospective study - Abstract March 12, 2014

Variation in use of active surveillance among men undergoing expectant management for early-stage prostate cancer - Abstract March 12, 2014

Detection of lymph node metastases in patients with nodal prostate cancer relapse using (18)F/(11)C-choline-PET/CT - influence of size of nodal tumor infiltration and accuracy related to lymph node regions - Abstract March 12, 2014

Dietary carrot consumption and the risk of prostate cancer - Abstract March 12, 2014

Treatment-related complications of radiation therapy after radical prostatectomy: Comparative effectiveness of intensity-modulated versus conformal radiation therapy - Abstract March 12, 2014

Left lobe of the prostate during clinical prostate cancer screening: The dark side of the gland for right-handed examiners - Abstract March 11, 2014

Recurrent prostate cancer genomic alterations predict response to brachytherapy treatment - Abstract March 11, 2014

A combination trial of vaccine plus ipilimumab in metastatic castration-resistant prostate cancer patients: Immune correlates - Abstract March 11, 2014

Page 1054 of 1437